Dow Today: UnitedHealth Group (UNH) Lower

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

The Dow Jones Industrial Average ( ^DJI) is trading down 313.0 points (-2.4%) at 12,932 as of Wednesday, Nov 7, 2012, 11:35 a.m. ET. During this time, 404.8 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 582.4 million. The NYSE advances/declines ratio sits at 383 issues advancing vs. 2,575 declining with 75 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Holding back the Dow today is UnitedHealth Group (NYSE: UNH), which is lagging the broader Dow index with a $2.88 decline (-5.1%) bringing the stock to $53.52. This single loss is lowering the Dow Jones Industrial Average by 21.8 points or roughly accounting for 7% of the Dow's overall loss. Volume for UnitedHealth Group currently sits at 5.7 million shares traded vs. an average daily trading volume of 5.7 million shares.

UnitedHealth Group has a market cap of $56.47 billion and is part of the health care sector and health services industry. Shares are up 9.1% year to date as of Tuesday's close. The stock's dividend yield sits at 1.5%.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company has a P/E ratio of 10.5, below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

FREE for a limited time only: Get TheStreet Ratings #1 Stock Report NOW!.